(Q80397888)
Statements
Long-Term Cost Effectiveness of Interferon-beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis : An Econometric Model (English)
Claude Lepen
Patricia Coyle
Timothy Vollmer
Lance Blumhardt
Hervé Lilliu
Ariel Beresniak
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference